News

Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts ...
Former President Joe Biden’s recent prostate cancer diagnosis is reigniting discussions about routine screenings for the disease, The Washington Post reported May 20. Mr. Biden, 82, announced May 18 ...
Most people are unaware of the symptoms, wouldn't discuss them with a doctor and don't know the treatment options ...
Isaacs says that the positive correlation he and his colleagues found between the mutated MMS22L gene and prostate cancer ...
The interim clinical data from Theralase®'s multicenter Phase II Bacillus Calmette-Guérin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC") Carcinoma In-Situ ("CIS") study ("Study II") ...
Look back at celebs' cancer journeys... The All My Children alum announced in January 2025 that he had been diagnosed with prostate cancer, his third cancer diagnosis throughout his life.
Haydn Reid has a family history of prostate cancer. Picture: Dean Martin They also recommend testing males aged over 70 based on clinical assessment, including life expectancy, and earlier testing ...
The Zenflow Spring is leading the way in establishing a new category of treatment, First-Line Interventional Therapy or “FIT”, for patients suffering from benign prostatic hyperplasia (BPH) or ...
Now 36, she's sharing her story in disbelief, as no cancer has been detected in her body after years of uncertainty. Dimery was enrolled in a clinical trial at the University of Minnesota.
A urine test for prostate cancer has proved to be far more accurate at detection than the current blood tests used. The new technique is now the ‘prime candidate’ for potential clinical trials ...
and many clinical trials are underway. In 2022, Pluvicto became the first theranostic to receive FDA approval for the treatment of advanced metastatic prostate cancer. (Additional indications ...
Large-scale clinical trials are being planned for the next phase of the research. One such is being discussed with Professor Rakesh Heer of Imperial College London, co-author of the study and head of ...